\
&
Contact us
\
&
Contact us
The objective of the European Partnership on Raw Materials is to strengthen the co-ordination of national and regional research programmes in the field of non-energy and non-agricultural raw materials, ensuring common understanding of R&I challenges to achieve the objectives of the Critical Raw Materials Act.
- The Partnership will build on the experience of ERA-NETs: ERA-MIN, ERA-MIN 2 and ERA-MIN 3.
- In May 2024, the Strategic Research & Innovation Agenda for the Partnership was published.
- On 9 December 2024, the Commission and the ERA-MIN 3 team co-organised a workshop on the future co-funded partnership on Raw Materials for the Green and Digital Transition. During the workshop the thematic priorities for the first call of the partnership were discussed, setting the stage for future collaboration and innovation.
Partnerships group the EC and private and/or public partners, to coordinate and streamline the research & innovation initiatives and funding in some selected key domains.
Ria.debreucker@vlaio.be
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
